Pharmesis International Ltd. (SGX:BFK)
Singapore
· Delayed Price · Currency is SGD 0.350
0.00 (0.00%)
At close: Mar 5, 2026
Pharmesis International Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 43.75 | 67.65 | 45.64 | 50.37 | 52.77 | Upgrade
|
| Revenue Growth (YoY) | -35.32% | 48.24% | -9.40% | -4.55% | 12.01% | Upgrade
|
| Cost of Revenue | 27.92 | 43.5 | 24.82 | 26.36 | 27.77 | Upgrade
|
| Gross Profit | 15.84 | 24.15 | 20.82 | 24.01 | 25 | Upgrade
|
| Selling, General & Admin | 21.15 | 22.13 | 23.61 | 26.54 | 23.94 | Upgrade
|
| Operating Expenses | 21.15 | 22.13 | 23.61 | 26.54 | 23.94 | Upgrade
|
| Operating Income | -5.31 | 2.02 | -2.8 | -2.53 | 1.06 | Upgrade
|
| Interest Expense | -0.69 | -0.7 | -0.87 | -0.94 | -1.04 | Upgrade
|
| Interest & Investment Income | - | 0 | 0.02 | 0.03 | 0.03 | Upgrade
|
| Currency Exchange Gain (Loss) | - | 0 | 0.05 | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | 2 | 0.19 | -1.26 | 0.28 | 2.06 | Upgrade
|
| EBT Excluding Unusual Items | -4 | 1.53 | -4.86 | -3.16 | 2.12 | Upgrade
|
| Asset Writedown | - | 6.91 | - | - | - | Upgrade
|
| Pretax Income | -4 | 8.44 | -4.86 | -3.16 | 2.12 | Upgrade
|
| Income Tax Expense | 0.31 | 0.83 | 0.05 | 0.02 | 0.15 | Upgrade
|
| Earnings From Continuing Operations | -4.3 | 7.61 | -4.9 | -3.18 | 1.97 | Upgrade
|
| Minority Interest in Earnings | - | 0.67 | -0.05 | -0.38 | -0.8 | Upgrade
|
| Net Income | -4.3 | 8.28 | -4.96 | -3.56 | 1.17 | Upgrade
|
| Net Income to Common | -4.3 | 8.28 | -4.96 | -3.56 | 1.17 | Upgrade
|
| Shares Outstanding (Basic) | 32 | 30 | 26 | 23 | 23 | Upgrade
|
| Shares Outstanding (Diluted) | 32 | 30 | 26 | 23 | 23 | Upgrade
|
| Shares Change (YoY) | 5.88% | 13.08% | 14.85% | - | - | Upgrade
|
| EPS (Basic) | -0.14 | 0.28 | -0.19 | -0.15 | 0.05 | Upgrade
|
| EPS (Diluted) | -0.14 | 0.28 | -0.19 | -0.15 | 0.05 | Upgrade
|
| Free Cash Flow | 0.28 | -4.24 | -12.17 | 6.33 | -0.93 | Upgrade
|
| Free Cash Flow Per Share | 0.01 | -0.14 | -0.46 | 0.28 | -0.04 | Upgrade
|
| Gross Margin | 36.20% | 35.70% | 45.61% | 47.67% | 47.38% | Upgrade
|
| Operating Margin | -12.13% | 2.99% | -6.13% | -5.02% | 2.01% | Upgrade
|
| Profit Margin | -9.83% | 12.24% | -10.86% | -7.07% | 2.22% | Upgrade
|
| Free Cash Flow Margin | 0.63% | -6.26% | -26.66% | 12.56% | -1.76% | Upgrade
|
| EBITDA | -3.13 | 3.24 | -1.62 | -1.19 | 2.33 | Upgrade
|
| EBITDA Margin | -7.15% | 4.78% | -3.54% | -2.36% | 4.42% | Upgrade
|
| D&A For EBITDA | 2.18 | 1.21 | 1.18 | 1.34 | 1.27 | Upgrade
|
| EBIT | -5.31 | 2.02 | -2.8 | -2.53 | 1.06 | Upgrade
|
| EBIT Margin | -12.13% | 2.99% | -6.13% | -5.02% | 2.01% | Upgrade
|
| Effective Tax Rate | - | 9.80% | - | - | 7.04% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.